This is the case with increased expression of galectin-3, a beta-galactoside-binding protein, which inhibits adhesion between tumor cells and with extracellular matrix, and therefore promotes cell mobility and tumor invasiveness (Liu and Rabinovich, 2005; Farhad et al., 2018). The gene discussed is LGALS3; the disease is neoplasm.